Cargando…
EBP50 regulates the apoptosis of pancreatic cancer cells by decreasing the expression levels of Bcl-2
Increasing evidence has demonstrated that ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 (EBP50) is involved in the malignant transformation of numerous human cancers. The present study investigated the involvement of EBP50 overexpression in the tumorigenicity of pancreatic cancer (PC). The re...
Autores principales: | JI, MENGYAO, YUAN, LEI, LV, XIAOGUANG, DONG, WEIGUO, PENG, XIULAN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113643/ https://www.ncbi.nlm.nih.gov/pubmed/25120624 http://dx.doi.org/10.3892/etm.2014.1831 |
Ejemplares similares
-
EBP50 inhibits pancreatic cancer cell growth and invasion by targeting the β-catenin/E-cadherin pathway
por: JI, MENGYAO, et al.
Publicado: (2015) -
Clinical significance of EBP50 overexpression assessed by quantum dot analysis in gastric cancer
por: LV, XIAO-GUANG, et al.
Publicado: (2013) -
EBP50 induces apoptosis in macrophages by upregulating nitric oxide production to eliminate intracellular Mycobacterium tuberculosis
por: Guo, Yang, et al.
Publicado: (2016) -
C/EBPα or C/EBPα oncoproteins regulate the intrinsic and extrinsic apoptotic pathways by direct interaction with NF-κB p50 bound to the bcl-2 and FLIP gene promoters
por: Paz-Priel, I, et al.
Publicado: (2008) -
PDZ interactions regulate rapid turnover of the scaffolding protein EBP50 in microvilli
por: Garbett, Damien, et al.
Publicado: (2012)